Literature DB >> 6729472

Genetic screening: marvel or menace?

P T Rowley.   

Abstract

Genetic screening is a systematic search in the population for persons of certain genotypes. The usual purpose is to detect persons who themselves or whose offspring are at risk for genetic diseases or genetically determined susceptibilities to environmental agents. Is genetic screening a marvel about to free us from the scourge of genetic disease or a menace about to invade our privacy and determine who may reproduce? There are three different types of genetic screening. Newborn screening identifies serious genetic disease at birth, permitting prompt treatment to prevent mental and physical retardation. Fetal screening and prenatal diagnosis identify genetic disease in the fetus permitting selective termination of pregnancy and the opportunity to have children free of defects detectable in utero. Carrier screening identifies individuals heterozygous for a gene for a serious recessive disease who may be at risk for affected offspring. The challenge to society is to provide (by way of cost-effective programs) expert services, including genetic counseling and follow-up, to all who may benefit, to ensure confidentiality and freedom of choice, and to avoid misunderstanding and stigmatization. It is recommended that the objective of screening programs should be to maximize the options available to families at risk rather than to reduce the incidence of genetic diseases. Whenever possible, the providers of these services should be the providers of primary health care. Urgently needed are a greater awareness of avoidable genetic diseases on the part of primary care providers and efforts to familiarize the public with the basic concepts of human genetics through the public school system.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction

Mesh:

Year:  1984        PMID: 6729472     DOI: 10.1126/science.6729472

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  The "new genetics": an ethical perspective from family practice.

Authors:  J Sugiyama
Journal:  Can Fam Physician       Date:  1988-04       Impact factor: 3.275

2.  Public attitudes toward fetal diagnosis and the termination of life.

Authors:  Eleanor Singer
Journal:  Soc Indic Res       Date:  1993

3.  Genetic discrimination and the law.

Authors:  M R Natowicz; J K Alper; J S Alper
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

4.  Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications.

Authors:  Jonathan C Goldsmith; Vence L Bonham; Clinton H Joiner; Gregory J Kato; Allan S Noonan; Martin H Steinberg
Journal:  Am J Hematol       Date:  2012-02-03       Impact factor: 10.047

5.  A review of biochemical and ultrasound markers in the detection of down syndrome.

Authors:  Catherine C Peterson
Journal:  J Perinat Educ       Date:  2006

Review 6.  Molecular genetics of common diseases.

Authors:  J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

7.  Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.

Authors:  M C Cornel; A S Breed; J R Beekhuis; G J te Meerman; L P ten Kate
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

8.  Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

9.  Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

10.  Introduction: new technologies for genetic and newborn screening.

Authors:  M R Seashore; C Walsh-Vockley
Journal:  Yale J Biol Med       Date:  1991 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.